U.S. markets open in 7 hours 28 minutes

Cresco Ltd. (CEJOF)

Other OTC - Other OTC Delayed Price. Currency in USD
13.840.00 (0.00%)
At close: 09:38AM EDT
  • Dividend

    CEJOF announced a cash dividend of 25.00 with an ex-date of Sep. 28, 2023

Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Neutralpattern detected
Previous Close13.84
BidN/A x N/A
AskN/A x N/A
Day's Range13.84 - 13.84
52 Week Range13.03 - 16.07
Avg. Volume0
Market Cap285.594M
Beta (5Y Monthly)0.84
PE Ratio (TTM)12.58
EPS (TTM)1.10
Earnings DateN/A
Forward Dividend & Yield0.37 (2.67%)
Ex-Dividend DateSep 28, 2023
1y Target EstN/A
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value

Subscribe to Yahoo Finance Plus to view Fair Value for CEJOF

View details
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
    WABC: Lowering target price to $45.00WESTAMERICA BANCORPORATION has an Investment Rating of BUY; a target price of $45.000000; an Industry Subrating of High; a Management Subrating of Medium; a Safety Subrating of Medium; a Financial Strength Subrating of Medium; a Growth Subrating of Medium; and a Value Subrating of High.
    Fair Value
    Economic Moat
    3 months agoArgus Research
View more
  • Reuters

    Cannabis firms Cresco, Columbia Care to terminate $2 billion merger

    The deal was seen as a bet on a U.S. pot industry boom, and executives then said the combined entity had the potential to be a brand as big as Coca-Cola or Johnnie Walker, with the merger helping it dominate a market likely to hit $46 billion by 2026. "In light of the evolving landscape in the cannabis industry, we believe the decision to terminate the planned transaction is in the long-term interest of Cresco Labs and our shareholders," Cresco CEO Charles Bachtell said in a statement. Cresco and Columbia last month said they would not be able to complete the divestitures necessary to secure regulatory approvals to close the transaction.